{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"acute-monocytic-leukemia","columns":[{"gene":"","key":"population-49467f07899977644235","label":"Leukemia, acute monocytic","mondoId":"MONDO:0007896","onsetQualifier":null,"originColumnKey":"MONDO:0007896/OMIM:151380","originalViews":[{"key":"MONDO:0007896/OMIM:151380","label":"Leukemia, acute monocytic","scopeLabel":"OMIM:151380","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["b1014760bf0a0f0283e99336c9cad9e218799f937d4662294341ef05c8cc1d9a"],"recordQualifiers":{},"scopeLabel":"OMIM:151380","sourceIds":["OMIM:151380"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-78f572b3de5862a4e9f2","label":"Acute monoblastic/monocytic leukemia","mondoId":"MONDO:0007896","onsetQualifier":null,"originColumnKey":"MONDO:0007896/ORPHA:514","originalViews":[{"key":"MONDO:0007896/ORPHA:514","label":"Acute monoblastic/monocytic leukemia","scopeLabel":"ORPHA:514","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0b7b09bd3eb956339e8a330fc91fc56ebc36da76bf73bc6f98cf1763e920d237","2f3980a39e28b0ba4e0ef19e37728b70df9fbb1787cdad04a7a210caee343185","31e8363bb72c6dfff4c6ea53003ad021da1b24093134ff86cde54ba453dd9818","381f9bb4a05562ffb5964779a3701a0fd0c9a7b8a863f5325c75742987af21fb","3837ee6353c1742888d93d05e93f680ecce110741490976b078b0a3b75b6e2e6","3d50966e2b6a9d273edd9fccbf9d179d58f73e2c6d73ea64e2bc3ae75eddf618","46fbd68a6ae55f88158d66f1627587733fffc14b93211b49fc387536641be1df","662159a7c561857fde156ebdc665ef1037d94860d7a444474f145076b61033ca","6be70faff8021adfeb0670ee1f801b726816c9bfb84421759249835b64ae0fd7","88fc991efa4fe9bbd6832e3f301e0a96bba33c8ae99afc9b045a209477e78c8c","90b646bb5d7eb72e73726e483b0b2dfd2d23da398953d4ecd22b13eb1cd704e4","a6545d0c79b775839e33fff3912b01caf144960f3eb6cc1a3eaa6631a05751c3","c21d90cca5ff57b0fe113429b15aa8682f65b28e4d43216b60a785c18f4c15f7","c973a848482a83817d652342b0e2378193411071b0711e403e1bec2e2689911a","cb1b521cf931a84b5252c80ba1cfb68bc2829810d2934cf04f840e34556f32d4","cb8c20e17ccc85bdcf4b8163c902ccf6038066ef2daca3d246c781097a092ec3","d0f4ce48e5107be62e1ecd467f6a9903c50775e0cb27ebd71172375d4910b919","de60384dda2bd470814fb0b5f902be4e9eb25b59f270126b6cc7774999c84b05","de69154c4c9a73ee857bb5ee29ddf390e70eba16387b31878b7df1e802760278","e6500c523e05ab6e691e9931a9df6e22657ac31dc89cf34222610f7c0fe4a650"],"recordQualifiers":{},"scopeLabel":"ORPHA:514","sourceIds":["ORPHA:514"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-49467f07899977644235","population-78f572b3de5862a4e9f2"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0012145","HP:0004845","HP:0001903","HP:0001785","HP:0002039","HP:0031020","HP:0011787"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":21,"sourceGroups":{"omim":1,"orphanet":20}},"features":[{"hpoId":"HP:0012145","label":"Abnormality of multiple cell lineages in the bone marrow","primary":true},{"hpoId":"HP:0004845","label":"Acute monocytic leukemia","primary":true},{"hpoId":"HP:0001903","label":"Anemia","primary":true},{"hpoId":"HP:0001785","label":"Ankle swelling","primary":true},{"hpoId":"HP:0002039","label":"Anorexia","primary":true},{"hpoId":"HP:0031020","label":"Bone marrow hypercellularity","primary":true},{"hpoId":"HP:0011787","label":"Central hypothyroidism","primary":true},{"hpoId":"HP:0025289","label":"Cervical lymphadenopathy","primary":false},{"hpoId":"HP:0002875","label":"Exertional dyspnea","primary":false},{"hpoId":"HP:0012378","label":"Fatigue","primary":false},{"hpoId":"HP:0001945","label":"Fever","primary":false},{"hpoId":"HP:0001931","label":"Hypochromic anemia","primary":false},{"hpoId":"HP:0025435","label":"Increased circulating lactate dehydrogenase concentration","primary":false},{"hpoId":"HP:0001974","label":"Increased total leukocyte count","primary":false},{"hpoId":"HP:0100827","label":"Increased total lymphocyte count","primary":false},{"hpoId":"HP:0100520","label":"Oliguria","primary":false},{"hpoId":"HP:0100539","label":"Periorbital edema","primary":false},{"hpoId":"HP:0001730","label":"Progressive hearing impairment","primary":false},{"hpoId":"HP:0001482","label":"Subcutaneous nodule","primary":false},{"hpoId":"HP:0001824","label":"Weight loss","primary":false}],"ledeHtml":"Acute monoblastic/monocytic leukemia (AML-M5), is one of the most common subtypes of acute myeloid leukemia (AML; see this term) that is either comprised of more than 80% of monoblasts (AML-M5a) or 30-80% monoblasts with (pro)monocytic differentiation (AML-M5b). AML-M5 presents with asthenia, pallor, fever, and dizziness. Specific features of AML-M5 include hyperleukocytosis, propensity for extramedullary infiltrates, coagulation abnormalities including disseminated intravascular coagulation and neurological disorders. Leukemia cutis and gingival infiltration can also be seen. A characteristic translocation observed in AML-M5 is t(9;11).","mondoId":"MONDO:0007896","node":{"canonicalSlug":"acute-monocytic-leukemia","comparisons":[{"documentSha256":"733dc7fac60450cd00ce4dfa5f74fadc3fb768dcb72920a4b8e173c872bba942","key":"legacy-cytogenetically-normal-acute-myeloid-leukemia","kind":"legacy","label":"acute myeloid leukemia","memberIds":["MONDO:0007896","MONDO:0012883","MONDO:0017858","MONDO:0018871","MONDO:0018874","MONDO:0019455"],"mondoId":"MONDO:0018874","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/cytogenetically-normal-acute-myeloid-leukemia.733dc7fac60450cd00ce4dfa5f74fadc3fb768dcb72920a4b8e173c872bba942.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Acute monocytic leukemia","originalSourceId":"ORPHA:514","paragraphs":["Acute monoblastic/monocytic leukemia (AML-M5), is one of the most common subtypes of acute myeloid leukemia (AML; see this term) that is either comprised of more than 80% of monoblasts (AML-M5a) or 30-80% monoblasts with (pro)monocytic differentiation (AML-M5b). AML-M5 presents with asthenia, pallor, fever, and dizziness. Specific features of AML-M5 include hyperleukocytosis, propensity for extramedullary infiltrates, coagulation abnormalities including disseminated intravascular coagulation and neurological disorders. Leukemia cutis and gingival infiltration can also be seen. A characteristic translocation observed in AML-M5 is t(9;11)."],"rawAttribution":"MONDO:0007896","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:38:17Z","upstream":"ORPHA:514","url":"https://rarediseases.info.nih.gov/diseases/525"},"ownColumnKeys":["population-49467f07899977644235","population-78f572b3de5862a4e9f2"],"publication":"published","relationships":[{"kind":"parent","label":"monocytic leukemia","mondoId":"MONDO:0004600","slug":null},{"kind":"parent","label":"acute myeloid leukemia","mondoId":"MONDO:0018874","slug":"cytogenetically-normal-acute-myeloid-leukemia"},{"kind":"child","label":"adult acute monocytic leukemia","mondoId":"MONDO:0000875","slug":null},{"kind":"child","label":"aleukemic monocytic leukemia cutis","mondoId":"MONDO:0004051","slug":null},{"kind":"child","label":"subacute monocytic leukemia","mondoId":"MONDO:0004644","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"0b7b09bd3eb956339e8a330fc91fc56ebc36da76bf73bc6f98cf1763e920d237","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001730","is_excluded":false,"label":"Progressive hearing impairment","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2f3980a39e28b0ba4e0ef19e37728b70df9fbb1787cdad04a7a210caee343185","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001903","is_excluded":false,"label":"Anemia","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"31e8363bb72c6dfff4c6ea53003ad021da1b24093134ff86cde54ba453dd9818","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0025289","is_excluded":false,"label":"Cervical lymphadenopathy","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"381f9bb4a05562ffb5964779a3701a0fd0c9a7b8a863f5325c75742987af21fb","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100539","is_excluded":false,"label":"Periorbital edema","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3837ee6353c1742888d93d05e93f680ecce110741490976b078b0a3b75b6e2e6","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001785","is_excluded":false,"label":"Ankle swelling","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3d50966e2b6a9d273edd9fccbf9d179d58f73e2c6d73ea64e2bc3ae75eddf618","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001482","is_excluded":false,"label":"Subcutaneous nodule","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"46fbd68a6ae55f88158d66f1627587733fffc14b93211b49fc387536641be1df","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031020","is_excluded":false,"label":"Bone marrow hypercellularity","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"662159a7c561857fde156ebdc665ef1037d94860d7a444474f145076b61033ca","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012378","is_excluded":false,"label":"Fatigue","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6be70faff8021adfeb0670ee1f801b726816c9bfb84421759249835b64ae0fd7","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001931","is_excluded":false,"label":"Hypochromic anemia","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"88fc991efa4fe9bbd6832e3f301e0a96bba33c8ae99afc9b045a209477e78c8c","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0004845","is_excluded":false,"label":"Acute monocytic leukemia","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"90b646bb5d7eb72e73726e483b0b2dfd2d23da398953d4ecd22b13eb1cd704e4","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001974","is_excluded":false,"label":"Increased total leukocyte count","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a6545d0c79b775839e33fff3912b01caf144960f3eb6cc1a3eaa6631a05751c3","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002039","is_excluded":false,"label":"Anorexia","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"b1014760bf0a0f0283e99336c9cad9e218799f937d4662294341ef05c8cc1d9a","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:151380","disease_name":"Leukemia, acute monocytic","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0004845","is_excluded":false,"label":"Acute monocytic leukemia","onset_id":null,"reference":"OMIM:151380","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"c21d90cca5ff57b0fe113429b15aa8682f65b28e4d43216b60a785c18f4c15f7","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100520","is_excluded":false,"label":"Oliguria","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c973a848482a83817d652342b0e2378193411071b0711e403e1bec2e2689911a","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0025435","is_excluded":false,"label":"Increased circulating lactate dehydrogenase concentration","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cb1b521cf931a84b5252c80ba1cfb68bc2829810d2934cf04f840e34556f32d4","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001945","is_excluded":false,"label":"Fever","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cb8c20e17ccc85bdcf4b8163c902ccf6038066ef2daca3d246c781097a092ec3","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001824","is_excluded":false,"label":"Weight loss","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d0f4ce48e5107be62e1ecd467f6a9903c50775e0cb27ebd71172375d4910b919","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100827","is_excluded":false,"label":"Increased total lymphocyte count","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"de60384dda2bd470814fb0b5f902be4e9eb25b59f270126b6cc7774999c84b05","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012145","is_excluded":false,"label":"Abnormality of multiple cell lineages in the bone marrow","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"de69154c4c9a73ee857bb5ee29ddf390e70eba16387b31878b7df1e802760278","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002875","is_excluded":false,"label":"Exertional dyspnea","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e6500c523e05ab6e691e9931a9df6e22657ac31dc89cf34222610f7c0fe4a650","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011787","is_excluded":false,"label":"Central hypothyroidism","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/525\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0007896\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:514</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Acute monoblastic/monocytic leukemia (AML-M5), is one of the most common subtypes of acute myeloid leukemia (AML; see this term) that is either comprised of more than 80% of monoblasts (AML-M5a) or 30-80% monoblasts with (pro)monocytic differentiation (AML-M5b). AML-M5 presents with asthenia, pallor, fever, and dizziness. Specific features of AML-M5 include hyperleukocytosis, propensity for extramedullary infiltrates, coagulation abnormalities including disseminated intravascular coagulation and neurological disorders. Leukemia cutis and gingival infiltration can also be seen. A characteristic translocation observed in AML-M5 is t(9;11).</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/525\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"acute-monocytic-leukemia","sourceDocuments":[{"name":"GARD: Acute monocytic leukemia","reviewed":null,"source_release":"2026-10-25T03:38:17Z","url":"https://rarediseases.info.nih.gov/diseases/525"},{"name":"MONDO: acute monocytic leukemia","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0007896"}],"sourceNote":"","synonyms":["acute monoblastic leukaemia","acute monoblastic leukaemia and acute monocytic leukaemia","acute monoblastic leukemia","acute monoblastic/monocytic leukaemia","acute monoblastic/monocytic leukemia","acute monocytic leukaemia (FAB M5B)","acute monocytic leukaemia (FAB M5b)","acute monocytic leukemia","acute monocytic leukemia (FAB M5B)","acute monocytic leukemia (FAB M5b)","acute monocytic leukemia, morphology (morphologic abnormality)","acute myeloblastic leukaemia type 5","acute myeloblastic leukemia type 5","AML M5","AML-M5","leukemia, monocytic, malignant","monocytic leukemia, acute"],"takeawayHtml":"","title":"acute monocytic leukemia"},"schemaVersion":1}
